When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OTSKF - FDA OKs Otsuka's tolvaptan to slow kidney function decline in inherited kidney cyst disorder
Otsuka Holdings Co. Ltd.
The FDA approves Otsuka Pharmaceutical's (OTCPK:OTSKF)(OTCPK:OTSKY) JYNARQUE (tolvaptan) to slow the decline in kidney function in patients with rapidly progressing autosomal dominant polycystic kidney disease (ADPKD), an inherited disorder characterized by the formation of cysts in the kidneys that affects ~140K Americans. It is the first drug approved here for the indication.
More news on: Otsuka Holdings Co. Ltd., Otsuka Holdings Co. Ltd. ADR, Healthcare stocks news,